Effects of anti-schistosomal chemotherapy on immune responses, protection and immunity. II. Concomitant immunity and immunization with irradiated cercariae.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 3080913)

Published in Am J Trop Med Hyg on January 01, 1986

Authors

A F Tawfik, D G Colley

Articles by these authors

(truncated to the top 100)

C3 shunt activation in human serum chelated with EGTA. J Immunol (1972) 6.94

Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol (1993) 2.92

Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid. Infect Immun (1975) 2.04

Eosinophils and immune mechanisms. Eosinophil stimulation promoter (ESP): a lymphokine induced by specific antigen or phytohemagglutinin. J Immunol (1973) 1.89

Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am J Trop Med Hyg (1993) 1.87

Studies on schistosomiasis in western Kenya: I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. Am J Trop Med Hyg (1997) 1.83

Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am J Trop Med Hyg (1993) 1.73

Immune responses to a soluble schistosomal egg antigen preparation during chronic primary infection with Schistosoma mansoni. J Immunol (1975) 1.72

Cellular differentiation in the thymus. 3. Surface properties of rat thymus and lymph node cells separated on density gradients. J Exp Med (1970) 1.60

Immunologic aspects of host responses to schistosomiasis: resistance, immunopathology, and eosinophil involvement. Prog Allergy (1978) 1.39

Adoptive suppression of granuloma formation. J Exp Med (1976) 1.38

Schistosomiasis vaccine:research to development. Parasitol Today (1998) 1.38

Schistosomal egg antigen-induced lymphocyte blastogenesis in experimental murine Schistosoma mansoni infection. J Immunol (1971) 1.33

Schistosoma mansoni: simplified method for the production of schistosomules. Exp Parasitol (1974) 1.30

Immune responses during human schistosomiasis mansoni. V. Suppression of schistosome antigen-specific lymphocyte blastogenesis by adherent/phagocytic cells. J Immunol (1979) 1.30

Immune responses during human schistosomiasis mansoni. III. Regulatory effect of patient sera on human lymphocyte blastogenic responses to schistosome antigen preparations. Am J Trop Med Hyg (1977) 1.29

In vivo molecular analysis of lymphokines involved in the murine immune response during Schistosoma mansoni infection. II. Quantification of IL-4 mRNA, IFN-gamma mRNA, and IL-2 mRNA levels in the granulomatous livers, mesenteric lymph nodes, and spleens during the course of modulation. J Immunol (1992) 1.28

Immune responses during human schistosomiasis mansoni. I. In vitro lymphocyte blastogenic responses to heterogeneous antigenic preparations from schistosome eggs, worms and cercariae. Int Arch Allergy Appl Immunol (1977) 1.28

Modulation of Schistosoma mansoni egg-induced granuloma formation: I-J restriction of T cell-mediated suppression in a chronic parasitic infection. Proc Natl Acad Sci U S A (1981) 1.27

Prevalence of trachoma in school children and ophthalmological outpatients in rural Egypt. Am J Trop Med Hyg (1987) 1.27

The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals. AIDS (2000) 1.26

Cellular immune responses of schistosomiasis patients are altered by human immunodeficiency virus type 1 coinfection. J Infect Dis (2001) 1.24

In vivo effects of monoclonal anti-L3T4 antibody on immune responsiveness of mice infected with Schistosoma mansoni. Reduction of irradiated cercariae-induced resistance. J Immunol (1988) 1.23

Adoptive suppression of granuloma formation by T lymphocytes and by lymphoid cells sensitive to cyclophosphamide. Cell Immunol (1979) 1.23

Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1. Am J Trop Med Hyg (1998) 1.20

Eosinophils and immune mechanisms: production of the lymphokine eosinophil stimulation promoter (ESP) in vitro by isolated intact granulomas. J Reticuloendothel Soc (1975) 1.19

Schistosoma mansoni: eosinophilia and the development of lymphocyte blastogenesis in response to soluble egg antigen in inbred mice. Exp Parasitol (1972) 1.17

Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease. Int Immunol (1994) 1.16

Immune responses during human schistosomiasis mansoni. IV. Induction of suppressor cell activity by schistosome antigen preparations and concanavalin A. J Immunol (1978) 1.15

Schistosoma mansoni infection in mice depleted of thymus-dependent lymphocytes. I. Eosinophilia and immunologic responses to a schistosomal egg preparation. Am J Pathol (1973) 1.14

Chagasic patients lack CD28 expression on many of their circulating T lymphocytes. Scand J Immunol (1996) 1.14

Intradermal immune responses to a schistosomal egg antigen during experimental murine Schistosoma mansoni infection. Proc Soc Exp Biol Med (1972) 1.14

Schistosoma mansoni infection in mice depleted of thymus-dependent lymphocytes. II. Pathology and altered pathogenesis. Am J Pathol (1973) 1.13

Mixed lymphocyte blastogenesis in response to multiple histocompatibility antigens. J Immunol (1969) 1.12

Susceptibility and resistance to Schistosoma mansoni reinfection: parallel cellular and isotypic immunologic assessment. Am J Trop Med Hyg (2000) 1.11

Immune responses during human schistosomiasis mansoni. X. Production and standardization of an antigen-induced mitogenic activity by peripheral blood mononuclear cells from treated, but not active cases of schistosomiasis. J Immunol (1983) 1.11

T lymphocytes that contribute to the immunoregulation of granuloma formation in chronic murine schistosomiasis. J Immunol (1981) 1.08

Cytokine regulation of human immune response to Schistosoma mansoni: analysis of the role of IL-4, IL-5 and IL-10 on peripheral blood mononuclear cell responses. Scand J Immunol (1997) 1.06

Interferon-gamma production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni. Trans R Soc Trop Med Hyg (1995) 1.04

Cytotoxic effect of normal rabbit serum on rat lymphoid cells. Transplantation (1970) 1.04

Expression of major histocompatibility complex antigens and adhesion molecules in hearts of patients with chronic Chagas' disease. Am J Trop Med Hyg (1993) 1.03

Immune responses during human Schistosomiasis mansoni. VIII. Differential in vitro cellular responsiveness to adult worm and schistosomular tegumental preparations. Am J Trop Med Hyg (1983) 1.02

Immune responses during human schistosomiasis. XII. Differential responsiveness in patients with hepatosplenic disease. Am J Trop Med Hyg (1986) 1.02

Eosinophil-mediated destruction of Schistosoma mansoni eggs III. lymphokine involvement in the induction of eosinophil functional abilities. Cell Immunol (1978) 1.01

Immune responses during human schistosomiasis mansoni. VI. In vitro nonspecific suppression of phytohemagglutinin responsiveness induced by exposure to certain schistosomal preparations. J Immunol (1979) 1.00

Partial purification and characterization of Schistosoma mansoni soluble egg antigen with Con A-Sepharose chromatography. J Immunol (1979) 1.00

Immunoaffinity purification of Schistosoma mansoni soluble egg antigens. J Immunol (1979) 0.98

Comparison of antibody isotype responses to Schistosoma mansoni antigens by infected and putative resistant individuals living in an endemic area. Parasite Immunol (1995) 0.98

Immune responses during human schistosomiasis mansoni. XVIII. Immunologic status of pregnant women and their neonates. Scand J Immunol (1992) 0.98

Human antibody responses against schistosomal antigens. I. Antibodies from patients with Ancylostoma, Ascaris lumbricoides or Schistosoma mansoni infections react with schistosome antigens. Am J Trop Med Hyg (1988) 0.98

Idiotypic sensitization in utero of children born to mothers with schistosomiasis or Chagas' disease. J Clin Invest (1989) 0.97

Self and nonself stimulatory molecules induce preferential expansion of CD5+ B cells or activated T cells of chagasic patients, respectively. Scand J Immunol (2000) 0.97

Eosinophils and immune mechanisms. VI. The synergistic combination of granulocyte-macrophage colony-stimulating factor and IL-5 accounts for eosinophil-stimulation promoter activity in Schistosoma mansoni-infected mice. J Immunol (1990) 0.96

Schistosoma mansoni: relationship of tumor necrosis factor-alpha to morbidity and collagen deposition in chronic experimental infection. Exp Parasitol (1996) 0.96

Eosinophil-mediated destruction of Schistosoma mansoni eggs. J Reticuloendothel Soc (1976) 0.96

In vivo molecular analysis of lymphokines involved in the murine immune response during Schistosoma mansoni infection. I. IL-4 mRNA, not IL-2 mRNA, is abundant in the granulomatous livers, mesenteric lymph nodes, and spleens of infected mice. J Immunol (1991) 0.95

Spleen cells from Schistosoma mansoni-infected mice produce diffusible stimulator of eosinophilopoiesis in vivo. Nature (1976) 0.95

Cellular differentiation in the thymus. II. Thymus-specific antigens in rat thymus and peripheral lymphoid cells. J Immunol (1970) 0.94

Immune responses and immunoregulation in relation to human schistosomiasis in Egypt. III. Immunity and longitudinal studies of in vitro responsiveness after treatment. Trans R Soc Trop Med Hyg (1986) 0.94

Eosinophils and immune mechanisms. IV. Culture conditions, antigen requirements, production kinetics and immunologic specificity of the lymphokine eosinophil stimulation promoter. Cell Immunol (1976) 0.93

Eosinophils and immune mechanisms. II. Partial characterization of the lymphokine eosinophil stimulation promoter. J Immunol (1974) 0.92

Neonatal exposure to idiotype induces Schistosoma mansoni egg antigen-specific cellular and humoral immune responses. J Immunol (1999) 0.92

Schistosoma mansoni: susceptibility differences between male and female mice can be mediated by testosterone during early infection. Exp Parasitol (1997) 0.92

Schistosoma japonicum soluble egg antigens: separation by can A chromatography and immunoaffinity purification. Mol Immunol (1981) 0.92

Two distinct pathological syndromes in male CBA/J inbred mice with chronic Schistosoma mansoni infections. Am J Pathol (1993) 0.92

Influence of parasite presence on the immunologic profile of peripheral blood mononuclear cells from chagasic patients after specific drug therapy. Parasite Immunol (1996) 0.91

Eosinophils and immune mechanisms. III. Production of the lymphokine eosinophil stimulation promoter by mouse T lymphocytes. J Immunol (1976) 0.90

Neonatal idiotypic exposure alters subsequent cytokine, pathology, and survival patterns in experimental Schistosoma mansoni infections. J Exp Med (1999) 0.90

Immune responses during human schistosomiasis mansoni. XVI. Idiotypic differences in antibody preparations from patients with different clinical forms of infection. J Immunol (1989) 0.90

Immunoregulatory idiotypes stimulate T helper 1 cytokine responses in experimental Schistosoma mansoni infections. J Immunol (1997) 0.89

T-cell repertoire analysis in acute and chronic human Chagas' disease: differential frequencies of Vbeta5 expressing T cells. Scand J Immunol (2000) 0.89

Modulation of Schistosoma mansoni egg-induced granuloma formation. III. Evidence for an anti-idiotypic, I-J-positive, I-J-restricted, soluble T suppressor factor. J Immunol (1984) 0.89

Schistosoma mansoni: mortality, pathophysiology, and susceptibility differences in male and female mice. Exp Parasitol (1992) 0.88

Immune responses during human schistosomiasis mansoni. IX. T-lymphocyte subset analysis by monoclonal antibodies in hepatosplenic disease. Scand J Immunol (1983) 0.88

An electrophoretic analysis of Schistosoma mansoni soluble egg antigen preparation. J Parasitol (1978) 0.88

Complement-dependent platelet injury by staphylococcal protein A. J Exp Med (1972) 0.87

IL-10 deficit correlates with chronic, hypersplenomegaly syndrome in male CBA/J mice infected with Schistosoma mansoni. Parasite Immunol (1997) 0.87

Arachidonic acid metabolism of the murine eosinophil. II. Involvement of the lipoxygenase pathway in the response to the lymphokine eosinophil stimulation promoter. J Immunol (1982) 0.87

Immunopathology of dermal reactions induced by Schistosoma mansoni cercariae and cercarial extract. Am J Trop Med Hyg (1972) 0.87

Mouse model for Chagas disease: immunohistochemical distribution of different stages of Trypanosoma cruzi in tissues throughout infection. Am J Trop Med Hyg (2001) 0.87

Serologic responses to Schistosoma japonicum: evaluation of total and parasite-specific immunoglobulins during the course of murine infection. J Parasitol (1982) 0.87

Expression of cross-reactive, shared idiotypes on anti-SEA antibodies from humans and mice with schistosomiasis. J Immunol (1990) 0.86

Alternate complement pathway induction of aggregation and release of 5-hydroxytryptamine and adenosine diphosphate by rabbit platelets. J Immunol (1975) 0.86

Antimicrobial resistance and prevalence of extended spectrum beta-lactamase among clinical isolates of gram-negative bacteria in Riyadh. J Chemother (1995) 0.86

Schistosome Antigen Laboratory Workshop: summary of a meeting sponsored by the Edna McConnell Clark Foundation. J Parasitol (1983) 0.86

Humoral immune responses in human hepatosplenic schistosomiasis mansoni. Am J Trop Med Hyg (1978) 0.86

Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas' disease. Am J Trop Med Hyg (1996) 0.86

Eosinophi-mediated destruction of Schistosoma mansoni eggs in vitro. II. The role of cytophilic antibody. Cell Immunol (1978) 0.86

Immune responses during human schistosomiasis mansoni. XV. Anti-idiotypic T cells can recognize and respond to anti-SEA idiotypes directly. J Immunol (1988) 0.86

Immune responses during human schistosomiasis mansoni. VII. Further analysis of the interactions between patient sera and lymphocytes during in vitro blastogenesis to schistosome antigen preparations. Am J Trop Med Hyg (1980) 0.86

Immune responses during human Schistosomiasis mansoni. XI. Immunologic status of patients with acute infections and after treatment. J Immunol (1985) 0.86

Immune responses and immunoregulation in relation to human schistosomiasis in Egypt. II. Cimetidine reversal of histamine-mediated suppression of antigen-induced blastogenesis. J Immunol (1984) 0.85

Demonstration of splenic auto-anti-idiotypic plaque-forming cells in mice infected with Schistosoma mansoni. J Immunol (1985) 0.85

Post-antibiotic effect of azithromycin and erythromycin on streptococcal susceptibility to phagocytosis. J Med Microbiol (1995) 0.85

Variations in peripheral blood eosinophil levels in normal and Schistosoma mansoni-infected mice. J Lab Clin Med (1974) 0.85

Idiotypic/anti-idiotypic interactions in schistosomiasis and Chagas' disease. Am J Trop Med Hyg (1988) 0.84

Immunopathogenesis and immunoregulation in schistosomiasis. Distinct chronic pathologic syndromes in CBA/J mice. Ann N Y Acad Sci (1996) 0.84

Schistosoma mansoni: detection of circulating antigens in murine schistosomiasis by antigen-capture sandwich ELISA using a monoclonal antibody. Exp Parasitol (1990) 0.84

Differences in adult Schistosoma mansoni worm burden requirements for the establishment of resistance to reinfection in inbred mice. I. CBA/J and C57BL/6 mice. Am J Trop Med Hyg (1980) 0.84

Differences in adult Schistosoma mansoni worm burden requirements for the establishment of resistance to reinfection in inbred mice. II. C57BL/KsJ, SWR/J, SJL/J, BALB/cAnN, DBA/2N, A/J, B10.A(3R), and B10.A(5R) mice. Am J Trop Med Hyg (1983) 0.84